Sorrento Therapeutics
Pre-clinicalSorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19
Founded
2006
Focus
DiagnosticsSmall Molecules
About
Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19
Funding History
3Total raised: $250M
Debt$75MUndisclosedFeb 15, 2021
PIPE$150MUndisclosedMay 15, 2020
IPO$25MUndisclosedDec 17, 2009
Company Info
TypePrivate
Founded2006
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile